CRMI appoints Zhou Xudong as an independent non-executive director
According to the Zhitong Finance APP, China Regenerative Medicine announced that Liu Ming has resigned as an independent non-executive director due to personal matters and will no longer serve as the chairman of the audit committee, nomination committee, and remuneration committee, effective June 30, 2025. From the same date, Zhou Xudong has been appointed as an independent non-executive director, a member of the audit committee, and the chairman of both the remuneration committee and the nomination committee
According to the Zhitong Finance APP, China Regenerative Medicine (08158) announced that Liu Ming has resigned as an independent non-executive director due to personal matters, and will no longer serve as the chairman of the company's audit committee, nomination committee, and remuneration committee, effective from June 30, 2025.
On the same day, Zhou Xudong has been appointed as an independent non-executive director, a member of the audit committee, and the chairman of both the remuneration committee and the nomination committee
